Reply to: Germline and Somatic BRCA1/2 Mutations in Breast Cancer Treatment Strategies

Hahnen E, Hauke J, Gelmon K, Marmé F, Ernst C, Martin M, Untch M, Bonnefoi H, Knudsen E, Im SA, Demichele A, Van't Veer L, Kim SB, Bear H, McCarthy N, Rhiem K, Turner N, Witkiewicz A, Rojo F, Filipits M, Martin LA, Fasching P, Schem C, Becker K, Garca-Sáenz JA, Kelly CM, Reimer T, Toi M, Rugo HS, Denkert C, Gnant M, Makris A, Liu Y, Valota O, Felder B, Weber K, Nekljudova V, Loibl S (2025)


Publication Language: English

Publication Type: Journal article, Letter

Publication year: 2025

Journal

Book Volume: 9

Article Number: e2500588

DOI: 10.1200/PO-25-00588

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Hahnen, E., Hauke, J., Gelmon, K., Marmé, F., Ernst, C., Martin, M.,... Loibl, S. (2025). Reply to: Germline and Somatic BRCA1/2 Mutations in Breast Cancer Treatment Strategies. JCO Precision Oncology, 9. https://doi.org/10.1200/PO-25-00588

MLA:

Hahnen, Eric, et al. "Reply to: Germline and Somatic BRCA1/2 Mutations in Breast Cancer Treatment Strategies." JCO Precision Oncology 9 (2025).

BibTeX: Download